Issue link: https://beckershealthcare.uberflip.com/i/1472295
33 DEVICES & IMPLANTS NuVasive's Pulse surpasses 500 cases; robotics will be a 'key application' By Alan Condon N uVasive's Pulse integrated spine sur- gery system was a key growth driver in the first quarter and has been used in more than 500 commercial cases, the com- pany said in its first-quarter earnings call May 4, according to Seeking Alpha. Six notes: 1. NuVasive said it will continue to invest in the Pulse platform, Pulse robotics and its core spine portfolio. Its goal for Pulse is to have it be used in 100 percent of spine cases. NuVa- sive said it is developing financial models that will benefit the company and its customers. 2. e company continues to invest in robot- ics research and development to execute on its Pulse robotics roadmap, but it has "not yet submitted for regulatory approval and thus, we will not complete first in-human this year," CEO Chris Barry said. 3. ough the robotics application has been delayed, the company expects Pulse robotics to be a key application for the platform and will provide updates on upcoming milestones later. 4. NuVasive has also collaborated with Sie - mens Healthineers to integrate the Pulse platform with the Cios Spin mobile C-arm, "a leading intraoperative 2D and 3D imaging solution," according to the company. 5. Mr. Barry said NuVasive has also invested in data and analytics and preoperative sur- gical planning strategies to support the de- velopment of new applications for the Pulse system. 6. e device is a single unit of capital equip- ment that incorporates two fixed screens, wireless device connectivity and several so- ware technologies. Pulse's reduced footprint in the operating room provides increased ef- ficiency for surgeons and staff, according to NuVasive. n Who is Globus Medical's new CEO? 5 things to know By Alan Condon D aniel Scavilla is the new CEO of Globus Medical, succeeding Dave Demski, who stepped down to pursue other opportunities after 20 years with the company. Five things to know: 1. Mr. Scavilla has been with Globus Medical for seven years, joining as senior vice president and CFO in April 2015. He later became president of the company's trauma and joint reconstruction businesses before he was named executive vice president and chief commercial officer in 2019. 2. Before joining Globus Medical, he served as CFO and global vice president of finance and business operations at Johnson & Johnson, where he focused on the company's $3 billion vision care unit. 3. Mr. Scavilla also served as CFO and worldwide vice presi- dent of finance at Advanced Sterilization Products, the in- fection prevention branch of J&J Medical Devices. 4. He serves on the board of directors of Impulse Dynamics, a private company specializing in technology for treating heart conditions. 5. Mr. Scavilla has a bachelor's degree from LaSalle Univer- sity and a master's in business administration from Temple University, both in Philadelphia. n Spine device company opens robotic research, surgical training labs By Paige Haeffele M edical technology company Accelus opened its new robotic research and development lab in Louisville, Colo., and clinical education and surgical training lab in Carlsbad, Calif., bringing it one step closer to its goal of making minimally invasive surgery the industry standard for spine care. "Accessibility is a cornerstone of many of Accelus's core value propositions — accessibility to anatomy without compromise and accessibility for patients to receive care with our products in outpatient as well as inpatient facilities both domestically and internationally," Chris Walsh, Accelus CEO and co-found- er, said in a May 26 press release. "Giving our surgeons and their staff accessibility to clinical training without necessitating a transcontinental journey creates similar advantages to work- ing with Accelus." The labs work in conjunction with the company's corporate head- quarters and clinical education lab in Palm Beach Gardens, Fla. Most of Accelus's Remi Robotic Navigation Systems develop- ment team work at the 3,731-square-foot Louisville facility, which opened in late 2021. The space also offers spine surgeon train- ing and clinical staff training on how to incorporate the Remi sys- tem into spinal surgeries. The 5,722-square-foot Carlsbad facility opened in early 2022 and houses the company's second clinical education lab. n